Trupanion, Inc. (NASDAQ:TRUP) Receives $32.33 Average PT from Brokerages

Shares of Trupanion, Inc. (NASDAQ:TRUPGet Free Report) have been assigned an average rating of “Hold” from the five analysts that are covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average twelve-month price target among brokers that have covered the stock in the last year is $29.40.

Several research firms have commented on TRUP. Stifel Nicolaus raised their target price on shares of Trupanion from $25.00 to $28.00 and gave the company a “hold” rating in a research note on Friday, February 16th. Evercore ISI decreased their price target on Trupanion from $35.00 to $31.00 and set an “outperform” rating for the company in a research note on Tuesday, February 20th. Piper Sandler lowered their price target on Trupanion from $28.00 to $22.00 and set a “neutral” rating on the stock in a research report on Friday. Finally, Canaccord Genuity Group cut their price objective on Trupanion from $40.00 to $34.00 and set a “buy” rating for the company in a report on Friday.

Check Out Our Latest Stock Analysis on TRUP

Trupanion Price Performance

Shares of TRUP opened at $19.85 on Friday. Trupanion has a 12 month low of $18.45 and a 12 month high of $36.82. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.63 and a quick ratio of 1.63. The stock has a fifty day moving average price of $25.61 and a 200 day moving average price of $26.72. The company has a market cap of $833.50 million, a P/E ratio of -31.02 and a beta of 1.76.

Trupanion (NASDAQ:TRUPGet Free Report) last released its quarterly earnings results on Thursday, May 2nd. The financial services provider reported ($0.16) EPS for the quarter, topping the consensus estimate of ($0.18) by $0.02. The business had revenue of $306.12 million during the quarter, compared to analyst estimates of $300.51 million. Trupanion had a negative net margin of 2.31% and a negative return on equity of 9.10%. The company’s quarterly revenue was up 19.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($0.60) earnings per share. On average, research analysts forecast that Trupanion will post -0.43 earnings per share for the current year.

Hedge Funds Weigh In On Trupanion

Hedge funds and other institutional investors have recently modified their holdings of the stock. PNC Financial Services Group Inc. lifted its holdings in shares of Trupanion by 45.4% in the third quarter. PNC Financial Services Group Inc. now owns 2,990 shares of the financial services provider’s stock valued at $84,000 after purchasing an additional 933 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its position in Trupanion by 5.5% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 18,120 shares of the financial services provider’s stock worth $553,000 after acquiring an additional 948 shares during the period. Check Capital Management Inc. CA grew its stake in Trupanion by 4.7% during the 4th quarter. Check Capital Management Inc. CA now owns 24,000 shares of the financial services provider’s stock valued at $732,000 after acquiring an additional 1,075 shares in the last quarter. New York State Common Retirement Fund increased its holdings in shares of Trupanion by 1.4% in the 3rd quarter. New York State Common Retirement Fund now owns 79,142 shares of the financial services provider’s stock valued at $2,232,000 after purchasing an additional 1,101 shares during the period. Finally, BluePath Capital Management LLC purchased a new stake in shares of Trupanion in the third quarter worth approximately $31,000.

Trupanion Company Profile

(Get Free Report

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

See Also

Analyst Recommendations for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.